Category: Imaging & mpMRI

With an ever-increasing array of Artificial Intelligence (AI) applications in radiology, it’s a boom time for turning MRI into a powerhouse. In particular, both machine learning (ML) and deep learning (a particular type of ML) enable MRI of the prostate to branch out in new radiological directions. Out with the old, in with the new. keep reading

Do you use products labeled as eco-friendly? As a consumer, do you spend your dollars on goods and services that claim to do less (or no) damage to the environment? If so, you have joined the multitude of individuals who are aware that personal choices and actions can impact air and water pollution. Since the keep reading

Prostate cancer (PCa) is the most common non-skin cancer in men, and it’s one of the most curable if it’s detected early. In addition, the American Cancer Society points out, “Catching cancer early often allows for more treatment options.” This is definitely true for PCa, since the number of available treatment methods has grown in keep reading

Since the early 1990s, prostate needle biopsy using transrectal ultrasound (TRUS) guidance has been the reigning method for diagnosing prostate cancer. Compared to prior biopsy methods, it was a relative walk in the park. Transrectal ultrasound not only made prostate biopsy less invasive, it also had... keep reading

Frank Robinson is remembered for a successful career as a Major League outfielder (14-time All Star) and manager. He is less remembered as the originator of common proverb, “Close only counts in horseshoes and hand grenades.” According to ESPN Classic, in the July 31, 1973 issue of Time magazine Robinson uttered these words with respect keep reading

The Prostate MRI Imaging Study (PROMIS) was a landmark event in terms of demonstrating the superiority of multiparametric MRI (mpMRI) for biopsy guidance vs. conventional TRUS (transrectal ultrasound) guidance. Within a few years, more studies began to appear regarding biparametric MRI (bpMRI)... keep reading

If were such a thing as a Olympics for radical prostatectomy (RP), you might expect to see a gold medal awarded to a center like Johns Hopkins Brady Urological Institute, or one earned by Patrick Walsh. Such centers and individuals demonstrated a track record for excellence in this surgery. In fact, RP is the statistical keep reading

Some men will do just about anything to avoid seeing a doctor until a symptom like pain or bleeding suddenly freaks them out. If you’re one of them, you may be contributing to a shorter life. Many cancers, including prostate cancer (PCa), have no early symptoms, yet that’s when they can still be cured. Failing keep reading

Imagine a world championship boxing match. The two contestants are different screening methods for prostate cancer (PCa). The winner will be crowned King of Screening. In one corner stands the current reigning champion, PSA. He has managed to retain the title for decades. Although some have questioned his ability to land accurate punches, he’s still keep reading

What’s more important: saving men’s lives or saving healthcare dollars? Obviously, saving life is the top priority. But, if the two values could be combined at a single stroke, who wouldn’t jump at it? The way to achieve this integration is spelled out in a Nov. 2022 online JAMA Oncology article. In “Cost effectiveness of keep reading